The DOI matches its Crossref record.
Determinants of nicotine intake while chewing nicotine polacrilex gum
Abstract
Nicotine polacrilex gum is widely used as substitution therapy during cigarette smoking cessation. We studied circadian blood nicotine concentrations, daily intake of nicotine, and extraction of nicotine from gum in smokers switched experimentally to 2 or 4 mg nicotine gum, 12 pieces per day. Nicotine levels and intake were much lower while chewing gum than during ad libitum smoking. Extraction of nicotine from gum by the chewer was incomplete, averaging 53% and 72% for 2 and 4 mg gum, and variable (more than twofold) among individuals. The systemic dose of nicotine was less than expected based on analysis of nicotine in the chewed gum. Disproportionately higher metabolite-to-nicotine ratios while chewing gum compared with smoking suggested that some nicotine was swallowed and underwent first-pass metabolism. Nicotine and metabolite data were used to estimate buccal vs. gastrointestinal absorption. Relative buccal absorption vs. swallowing of nicotine appears to be an important determinant of systemic nicotine intake.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Pharmacologic Aspects of Cigarette Smoking and Nicotine Addiction
Oates, J. A., Wood, A. J. J., & Benowitz, N. L. (1988) · New England Journal of Medicine · doi:10.1056/nejm198811173192005 · Cited by 971
Self-citationFarsalinos, K. E., Spyrou, A., Tsimopoulou, K., Stefopoulos, C., Romagna, G., & Voudris, V. (2014) · Scientific Reports · doi:10.1038/srep04133 · Cited by 435
Kamimori, G. H., Karyekar, C. S., Otterstetter, R., Cox, D. S., Balkin, T. J., Belenky, G. L., & Eddington, N. D. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00958-9 · Cited by 449
Clinical Pharmacology of Nicotine
Benowitz, N. L. (1986) · Annual Review of Medicine · doi:10.1146/annurev.me.37.020186.000321 · Cited by 352
Self-citationBirrenbach, T., & Böcker, U. (2004) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200411000-00019 · Cited by 321
Christen, A. (1991) · JAMA · doi:10.1001/jama.1991.03470220049025 · Cited by 297
Farsalinos, K., Romagna, G., Tsiapras, D., Kyrzopoulos, S., & Voudris, V. (2013) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph10062500 · Cited by 268
CYP2A6 genotype and the metabolism and disposition kinetics of nicotine
BENOWITZ, N., SWAN, G., JACOBIII, P., LESSOVSCHLAGGAR, C., & TYNDALE, R. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2006.08.011 · Cited by 217
Self-citationNicotine Replacement Therapy: What Has Been Accomplished - Can We Do Better?
Benowitz, N. L. (1993) · Drugs · doi:10.2165/00003495-199345020-00001 · Cited by 174
Self-citationAzzopardi, D., Liu, C., & Murphy, J. (2022) · Drug and Chemical Toxicology · doi:10.1080/01480545.2021.1925691 · Cited by 150
“Using reported nicotine extraction of 44–72% for gum NRT (Benowitz et al. 1987, Lunell and Lunell 2005a, Lunell and Curvall 2011, Digard et al. 2013a, Hansson et al. 2019), 30–39% for snus (Lunell and Lunell 2005a, Caraway and Chen 2013, Digard et al. 2013a, b, Lunell et al. 2020), and 56% and 59%…”
(2002) · PubMed · Cited by 139
Nicotine Gum, 2 and 4 mg, for Nicotine Dependence
Herrera, N., Franco, R., Herrera, L., Partidas, A., Rolando, R., & Fagerström, K. O. (1995) · Chest · doi:10.1378/chest.108.2.447 · Cited by 137
Suppression of nicotine intake during ad libitum cigarette smoking by high-dose transdermal nicotine
Benowitz, N. L., Zevin, S., & Jacob, P. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37887-5 · Cited by 108
“Nicotine intake from nicotine gum, nicotine nasal spray and nicotine inhalers is on average even lower than that delivered by nicotine patches (Benowitz et al., 1987, 1997).”
(1990) · doi:10.1007/bf02244008 · Cited by 93
ONCKEN, C. (1997) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(97)00309-8 · Cited by 77
Lunell, E., & Lunell, M. (2005) · Nicotine & Tobacco Research · doi:10.1080/14622200500125468 · Cited by 69
Dautzenberg, B., Nides, M., Kienzler, J.-L., & Callens, A. (2007) · BMC Clinical Pharmacology · doi:10.1186/1472-6904-7-11 · Cited by 26
“The new formulations for lozenges were compared to 2 and 4 mg nicotine polacrilex gum (Nicorette®), which are pharmacologically well-characterized and were the first oral NRT product on the market [15,26,34,35].”
InfluentialNicotine polacrilex dose effects: serum nicotine levels and sensory characteristics
Leischow, S. J., Sachs, D. P. L., Hansen, M. D., & Bostrom, A. G. (1995) · Psychopharmacology · doi:10.1007/bf02245177 · Cited by 6
“0 mg nicotine polacrilex, particularly when the results of other studies found peak levels of approximately 8-11 ng/ml after using the 2 mg dose for a whole day (Russell et al. 1976; West et al. 1984; Benowitz et al. 1987).”
Method
Metadata
- Authors
- Benowitz, N. L., Jacob, P., & Savanapridi, C.
- Venue
- Clinical Pharmacology and Therapeutics
- Publisher
- Wiley
- Published
- 1987-04
- Volume
- 41
- Issue
- 4
- Pages
- 467-473
- ISSN
- 0009-9236 (ISSN-L)
- 1532-6535
- OpenAlex
- W2075549509
- Cited by
- 176
- References
- 0
- FWCI
- 5.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.